6PYL
Crystal Structure of HLA-B*2703 in complex with KK10, an HIV peptide
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX2 |
Synchrotron site | Australian Synchrotron |
Beamline | MX2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2015-08-14 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 0.9537 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 50.847, 82.649, 104.755 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 30.400 - 1.520 |
R-factor | 0.203 |
Rwork | 0.201 |
R-free | 0.23000 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4g9d |
RMSD bond length | 0.010 |
RMSD bond angle | 1.030 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | BUSTER (2.10.3) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 44.240 | 1.550 |
High resolution limit [Å] | 1.520 | 1.520 |
Rpim | 0.040 | 0.423 |
Number of reflections | 68648 | 24151 |
<I/σ(I)> | 14.5 | 2.1 |
Completeness [%] | 100.0 | |
Redundancy | 7.3 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | EVAPORATION | 277 | 20-30% PEG 4K, 0.2M Na Acetate and 0.1M Na Citrate pH 5.6 |